2019 Press Releases

June 17, 2019
American Diabetes Association® Celebrates 70 Years of Fun, Educational Camps for Children
For 70 years, the American Diabetes Association (ADA) has hosted summer camps for children and teens with type 1 diabetes. In 2019 nearly 7,000 campers, their siblings, and children at-risk of type 2 diabetes, ages 4-17, will attend one of 80 camp sessions nationwide and enjoy a traditional summer camp experience in a medically-safe environment.

June 11, 2019
Canagliflozin Shown to Improve Cardiovascular and Renal Outcomes in People with Type 2 Diabetes and Kidney Disease
CREDENCE trial finds improved overall cardiovascular and kidney outcomes, according to results presented today at ADA’s Scientific Sessions.

June 11, 2019
Oral Semaglutide Reduces Occurrence of Major Cardiac Events in People with Type 2 Diabetes With High Cardiovascular Risk
PIONEER 6 study of 3,183 adults presented today at the ADA’s Scientific Sessions.

June 10, 2019
Access to Continuous Glucose Monitors in Pediatric Diabetes Populations Improves Glycemic Control, Reduces Hypoglycemia and Improves Satisfaction with Diabetes Care and Technology Use
Studies examining effectiveness of CGM among children, teens and young adults with type 1 diabetes presented at the ADA’s Scientific Sessions.

June 10, 2019
Linagliptin and Glimepiride Have Comparable Cardiovascular Safety Effects in Type 2 Diabetes at High Cardiovascular Risk
Results of CAROLINA trial, a multi-center, international clinical trial of more than 6,000 adults and the longest-running study dedicated to cardiovascular outcomes in people with type 2 diabetes, presented at ADA’s Scientific Sessions.

June 10, 2019
Dulaglutide is Safe and Effective for People with Type 2 Diabetes and Moderate to Severe Chronic Kidney Disease
Analysis of AWARD-7 study determined dulaglutide reduced events associated with end-stage kidney disease.

June 9, 2019
Delayed Onset of Type 2 Diabetes by Six Years or More Significantly Reduces Risk of Cardiovascular Disease and Microvascular Disease
Analysis of 30-year follow up of more than 500 adults in China examines the extent of increased cardiovascular risk can be attributed to diabetes.

June 9, 2019
Dulaglutide Reduces Cardiovascular Disease in People with Type 2 Diabetes
Presented at ADA’s Scientific Sessions, REWIND trial confirms dulaglutide reduces CVD risk regardless of CV history.

June 9, 2019
Two RISE Clinical Trials in Youth and Adults with Impaired Glucose Tolerance or Newly Diagnosed Type 2 Diabetes Reveal Surprising Differences in Beta-Cell (β-cell) Function During and After Treatment
RISE researchers present Adult Medication Study results at the ADA’s Scientific Sessions and share the first direct comparison for youth and adult studies.

June 9, 2019
Type 1 Diabetes May Affect Brain Development, Beginning in Early Childhood
DirecNet study indicates youth with early-onset T1D have mild but detectable differences in brain development, based on research presented at the ADA’s Scientific Sessions.

June 9, 2019
Consistent Use of Diabetes Technology Across Multiple Environments Benefits Youth with Diabetes
Use of diabetes devices at school and camp shows improved outcomes and more time-in-range for youth with type 1 diabetes, presented at the ADA’s Scientific Sessions.

June 9, 2019
Teplizumab Delays Clinical Diagnosis of Type 1 Diabetes, an Average of Two Years, According to Study Presented at ADA’s Scientific Sessions
TrialNet research indicates immune therapy can slow the progression to disease in people identified as high risk for developing T1D.

June 8, 2019
Researchers Find Accelerating Rates of Severe Complications in Young Adults with Youth-Onset Type 2 Diabetes
TODAY2 study data show more intensive management and monitoring required, according to research presented today at ADA’s Scientific Sessions.

June 8, 2019
New Recommendations for Time-in-Range Targets During Continuous Glucose Monitoring Presented Today at the ADA’s Scientific Sessions
43 experts from around the globe create the International Consensus on Time-in-Range (TIR) with clinical CGM targets to supplement the currently agreed-upon metrics for CGM-derived times in glucose ranges.

June 8, 2019
Insulin-Producing Beta Cells Are Not Irreversibly Lost in Early Type 2 Diabetes
Analysis of data over a two-year period finds losing weight and minimizing weight regain can potentially lead to remission of type 2 diabetes.

June 8, 2019
High Blood Pressure and Elevated Glucose Levels Present Comparable Risk for Young Adults with Type 1 Diabetes to Develop Heart Disease
Study of more than 600 people over 25 years indicates lower blood pressure goals beneficial.

June 8, 2019
Weight Loss from Low-Calorie Diet, Followed by Different Weight Management Programs, Provide Comparable Delays to Progression of Type 2 Diabetes
Cumulative three-year incidence rate of type 2 diabetes drops to 4%, according to PREVIEW intervention study presented today at the ADA’s Scientific Sessions.

June 5, 2019
Elizabeth R. Seaquist, MD, Receives the American Diabetes Association’s® First Lois Jovanovic Transformative Woman in Diabetes Award, presented in collaboration with Sansum Diabetes Research Institute
Elizabeth R. Seaquist, MD, has been selected to receive the American Diabetes Association’s® (ADA’s) first Lois Jovanovic Transformative Woman in Diabetes Award. This new award in honor of Lois Jovanovic, MD, an iconic scientist and physician who passed away in September 2018, recognizes a woman who has made a significant impact in diabetes care, research, education or public health.

June 4, 2019
Raghuram Nagarathna, MD, FRCP, DSc, Receives the American Diabetes Association’s® 2019 Vivian Fonseca and Nagendran Family Diabetes Research Award
Raghuram Nagarathna, MD, FRCP, DSc, has been selected to receive the American Diabetes Association’s® (ADA’s) 2019 Vivian Fonseca and Nagendran Family Diabetes Research Award. This award, given in memory of Mr. P. Nagendran, promotes and recognizes diabetes research focused on the South Asian, Asian American, Native Hawaiian and Pacific Islander populations, and/or research by a scientist from these areas.

June 3, 2019
American Diabetes Association® Issues Critical Updates to the 2019 Standards of Medical Care in Diabetes
Today, the American Diabetes Association® (ADA) issued important updates to the 2019 Standards of Medical Care in Diabetes (Standards of Care), in annotations as the Living Standards of Care, focused on improving cardiovascular and renal health in people with type 2 diabetes.

Items 1 - 20 of 48  123Next